371 related articles for article (PubMed ID: 19800951)
21. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
[TBL] [Abstract][Full Text] [Related]
22. Nociceptin antagonism: probing the receptor by N-acetyl oligopeptides.
Kocsis L; Orosz G; Magyar A; Al-Khrasani M; Kató E; Rónai AZ; Bes B; Meunier JC; Gündüz O; Tóth G; Borsodi A; Benyhe S
Regul Pept; 2004 Nov; 122(3):199-207. PubMed ID: 15491792
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor.
Rizzi A; Spagnolo B; Wainford RD; Fischetti C; Guerrini R; Marzola G; Baldisserotto A; Salvadori S; Regoli D; Kapusta DR; Calo G
Peptides; 2007 Jun; 28(6):1240-51. PubMed ID: 17532097
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.
Arduin M; Spagnolo B; Calò G; Guerrini R; Carrà G; Fischetti C; Trapella C; Marzola E; McDonald J; Lambert DG; Regoli D; Salvadori S
Bioorg Med Chem; 2007 Jul; 15(13):4434-43. PubMed ID: 17490886
[TBL] [Abstract][Full Text] [Related]
25. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
[TBL] [Abstract][Full Text] [Related]
26. In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH (2).
Kitayama M; McDonald J; Barnes TA; Calo' G; Guerrini R; Rowbotham DJ; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):369-76. PubMed ID: 17598088
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells.
Wright KE; McDonald J; Barnes TA; Rowbotham DJ; Guerrini R; Calo' G; Lambert DG
Neurosci Lett; 2003 Aug; 346(3):145-8. PubMed ID: 12853105
[TBL] [Abstract][Full Text] [Related]
28. Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity.
Kapusta DR; Thorkildsen C; Kenigs VA; Meier E; Vinge MM; Quist C; Petersen JS
J Pharmacol Exp Ther; 2005 Aug; 314(2):652-60. PubMed ID: 15855355
[TBL] [Abstract][Full Text] [Related]
29. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G
Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.
Rizzi A; Rizzi D; Marzola G; Regoli D; Larsen BD; Petersen JS; Calo' G
Br J Pharmacol; 2002 Oct; 137(3):369-74. PubMed ID: 12237257
[TBL] [Abstract][Full Text] [Related]
31. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
Mason SL; Ho M; Nicholson J; McKnight AT
Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of the bifunctional opioid ligand H-Dmt-Tic-Gly-NH-Bzl (UFP-505).
Dietis N; McDonald J; Molinari S; Calo G; Guerrini R; Rowbotham DJ; Lambert DG
Br J Anaesth; 2012 Feb; 108(2):262-70. PubMed ID: 22194444
[TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of the rhesus monkey nociceptin/orphanin FQ receptor.
Koga K; Ichikawa D; Nambu H; Azuma-Kanoh T; Sakai N; Takaki-Kawagoe H; Ozaki S; Ohta H
Genes Genet Syst; 2009 Oct; 84(5):319-25. PubMed ID: 20154418
[TBL] [Abstract][Full Text] [Related]
34. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the non-peptide nociceptin receptor agonist, Ro64-6198 in Chinese hamster ovary cells expressing recombinant human nociceptin receptors.
Hashiba E; Lambert DG; Jenck F; Wichmann J; Smith G
Life Sci; 2002 Mar; 70(15):1719-25. PubMed ID: 12002517
[TBL] [Abstract][Full Text] [Related]
36. Binding of GTPgamma[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor.
McDonald J; Lambert DG
Br J Pharmacol; 2010 Mar; 159(6):1286-93. PubMed ID: 20148892
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein G alpha qi5.
Camarda V; Fischetti C; Anzellotti N; Molinari P; Ambrosio C; Kostenis E; Regoli D; Trapella C; Guerrini R; Severo S; Calo G
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jun; 379(6):599-607. PubMed ID: 19183962
[TBL] [Abstract][Full Text] [Related]
38. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
Guerrini R; Carra' G; Calo' G; Trapella C; Marzola E; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2004 Jun; 63(6):477-84. PubMed ID: 15175020
[TBL] [Abstract][Full Text] [Related]
39. Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese hamster ovary cells expressing human nociceptin/orphanin FQ receptors.
Hashimoto Y; Calo' G; Guerrini R; Smith G; Lambert DG
Eur J Pharmacol; 2002 Aug; 449(1-2):17-22. PubMed ID: 12163101
[TBL] [Abstract][Full Text] [Related]
40. Structure activity studies of nociceptin/orphanin FQ(1-13)-NH2 derivatives modified in position 5.
Guerrini R; Marzola E; Trapella C; Pacifico S; Cerlesi MC; Malfacini D; Ferrari F; Bird MF; Lambert DG; Salvadori S; Calo G
Bioorg Med Chem; 2015 Apr; 23(7):1515-20. PubMed ID: 25716007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
